News ReleasesRSS
- Nov 22, 2023 Chugai Launches Phesgo Subcutaneous Combination for the Treatment of HER2-Positive Breast and Colorectal Cancer
- Nov 21, 2023 Organizational and Personnel Changes
- Nov 16, 2023 Chugai Receives the Best IR Award, the Greatest IR Improvement Premium Companies, and the Best Continual IR Efforts Premium Companies
- Nov 09, 2023 The Launch of Chugai’s New TV Commercial Featuring Tori Matsuzaka “Innovation Lab / AI-leveraging Drug Discovery”
- Nov 07, 2023 Non-Clinical Research Results of Chugai’s NXT007 Published in Journal of Thrombosis and Haemostasis
What's NewRSS
- Dec 06, 2023 The dates of the Financial Results for 2023 FY, 2024 Q1, Q2, and Q3 have been updated.
- Nov 30, 2023 Information Meeting on PHESGO®
- Nov 13, 2023 Events & Presentations has been updated with the Date of Chugai Information Meeting on Phesgo®
- Oct 24, 2023 Conference on FY 2023.12 Q3 Financial Results
- Oct 24, 2023 Financial Results for Third Quarter of Fiscal Year 2023 (Jan-Sep 2023)
Share price
Pick Up
About Chugai
-
- Company Outline
- Company Profile, Business Process, Directors & Officers, Organization.
-
- History of Chugai Pharmaceutical
- Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”
-
- R&D
- Easy-to-understand introduction of Chugai’s R&D structure, strategies and technologies.
